Related references
Note: Only part of the references are listed.A Call For Evidence-Based Medical Treatment Of Opioid Dependence In The United States And Canada
Bohdan Nosyk et al.
HEALTH AFFAIRS (2013)
Effectiveness of Methadone Maintenance Treatment in Prevention of Hepatitis C Virus Transmission among Injecting Drug Users
Seyed-Moayed Alavian et al.
HEPATITIS MONTHLY (2013)
Global epidemiology of hepatitis C virus infection: New estimates of age-specific antibody to HCV seroprevalence
Khayriyyah Mohd Hanafiah et al.
HEPATOLOGY (2013)
Epidemiology and natural history of HCV infection
Behzad Hajarizadeh et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2013)
Hepatitis C Avoidance in Injection Drug Users: A Typology of Possible Protective Practices
Catherine McGowan et al.
PLOS ONE (2013)
The rising prevalence of prescription opioid injection and its association with hepatitis C incidence among street-drug users
Julie Bruneau et al.
ADDICTION (2012)
Defining dosing pattern characteristics of successful tapers following methadone maintenance treatment: results from a population-based retrospective cohort study
Bohdan Nosyk et al.
ADDICTION (2012)
Can needle and syringe programmes and opiate substitution therapy achieve substantial reductions in hepatitis C virus prevalence? Model projections for different epidemic settings
Peter Vickerman et al.
ADDICTION (2012)
Methadone Maintenance Therapy Outcomes in Iran
Roya Noori et al.
SUBSTANCE USE & MISUSE (2012)
Factors associated with methadone treatment among injection drug users in Bangkok, Thailand
Nadia Fairbairn et al.
JOURNAL OF SUBSTANCE ABUSE TREATMENT (2012)
The impact of needle and syringe provision and opiate substitution therapy on the incidence of hepatitis C virus in injecting drug users: pooling of UK evidence
Katy M. E. Turner et al.
ADDICTION (2011)
A Systematic Review and Meta-Analysis of Interventions to Prevent Hepatitis C Virus Infection in People Who Inject Drugs
Holly Hagan et al.
JOURNAL OF INFECTIOUS DISEASES (2011)
Global epidemiology of hepatitis B and hepatitis C in people who inject drugs: results of systematic reviews
Paul K. Nelson et al.
LANCET (2011)
Attribution of Hepatitis C Virus Seroconversion Risk in Young Injection Drug Users in 5 US Cities
Holly Hagan et al.
JOURNAL OF INFECTIOUS DISEASES (2010)
HIV in people who use drugs 2 Prevention of HIV infection for people who inject drugs: why individual, structural, and combination approaches are needed
Louisa Degenhardt et al.
LANCET (2010)
HIV in people who use drugs 6 People who use drugs, HIV, and human rights
Ralf Jurgens et al.
LANCET (2010)
HIV prevention, treatment, and care services for people who inject drugs: a systematic review of global, regional, and national coverage
Bradley M. Mathers et al.
LANCET (2010)
Smoking of crack cocaine as a risk factor for HIV infection among people who use injection drugs
Kora DeBeck et al.
CANADIAN MEDICAL ASSOCIATION JOURNAL (2009)
Hepatitis C virus incidence among young street-involved IDUs in relation to injection experience
Elise Roy et al.
DRUG AND ALCOHOL DEPENDENCE (2009)
Incidence of hepatitis C in drug injectors: the role of homelessness, opiate substitution treatment, equipment sharing, and community size
N. Craine et al.
EPIDEMIOLOGY AND INFECTION (2009)
Acute Hepatitis C Virus Infection in Young Adult Injection Drug Users: A Prospective Study of Incident Infection, Resolution, and Reinfection
Kimberly Page et al.
JOURNAL OF INFECTIOUS DISEASES (2009)
Methadone maintenance therapy versus no opioid replacement therapy for opioid dependence
Richard P. Mattick et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2009)
Highly active antiretroviral therapy and survival in HIV-Infected injection drug users
Evan Wood et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2008)
Characteristics of injection drug users who participate in drug dealing: Implications for drug policy
Thomas Kerr et al.
JOURNAL OF PSYCHOACTIVE DRUGS (2008)
High hepatitis C virus prevalence and incidence among Canadian intravenous drug users
E. Roy et al.
INTERNATIONAL JOURNAL OF STD & AIDS (2007)
The contributions of hepatitis B virus and hepatitis C virus infections to cirrhosis and primary liver cancer worldwide
Joseph F. Perz et al.
JOURNAL OF HEPATOLOGY (2006)
Incidence and risk factors for hepatitis C seroconversion in injecting drug users in Australia
Lisa Maher et al.
ADDICTION (2006)
Factors associated with methadone maintenance therapy use among a cohort of polysubstance using injection drug users in Vancouver
T Kerr et al.
DRUG AND ALCOHOL DEPENDENCE (2005)
Four-year follow-up of imprisoned male heroin users and methadone treatment: mortality, re-incarceration and hepatitis C infection
KA Dolan et al.
ADDICTION (2005)
Staging for antiretroviral therapy among HIV-infected drug users
E Wood et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2004)
Injection drug use and the hepatitis C virus: Considerations for a targeted treatment approach - The case study of Canada
B Fischer et al.
JOURNAL OF URBAN HEALTH-BULLETIN OF THE NEW YORK ACADEMY OF MEDICINE (2004)
Opportunities for prevention:: Hepatitis C prevalence and incidence in a cohort of young injection drug users
CL Miller et al.
HEPATOLOGY (2002)
A continuing concern: HIV and hepatitis testing and prevalence among drug users in substitution programmes in Zurich, Switzerland
B Somaini et al.
AIDS CARE-PSYCHOLOGICAL AND SOCIO-MEDICAL ASPECTS OF AIDS/HIV (2000)
Prevalence of hepatitis C virus infection among injecting drug users in Glasgow 1990-1996: are current harm reduction strategies working?
A Taylor et al.
JOURNAL OF INFECTION (2000)
Share Paper
